771
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Human albumin purification: a modified and concise method

, , , &

References

  • Arroyo, V.; Garcia-Martinez, R.; Salvatella, X. Human Serum Albumin, Systemic Inflammation, and Cirrhosis. J. Hepatol. 2014, 61(2), 396–407. DOI: 10.1016/j.jhep.2014.04.012.
  • Fanali, G.; Di Masi, A.; Trezza, V.; Marino, M.; Fasano, M.; Ascenzi, P. Human Serum Albumin: From Bench to Bedside. Mol. Aspects Med. 2012, 33(3), 209–290. DOI: 10.1016/j.mam.2011.12.002.
  • Raoufinia, R.; Mota, A.; Keyhanvar, N.; Safari, F.; Shamekhi, S.; Abdolalizadeh, J. Overview of Albumin and Its Purification Methods. Adv. Pharm. Bull. 2016, 6(4), 495–507. DOI: 10.15171/apb.2016.063.
  • Shao, Q.; Hall, C. K. Allosteric Effects of Gold Nanoparticles on Human Serum Albumin. Nanoscale 2017, 9(1), 380–390. DOI: 10.1039/c6nr07665c.
  • Kratz, F.;. Albumin as a Drug Carrier: Design of Prodrugs, Drug Conjugates and Nanoparticles. J. Control Release 2008, 132(3), 171–183. DOI: 10.1016/j.jconrel.2008.05.010.
  • Caraceni, P.; Domenicali, M.; Tovoli, A.; Napoli, L.; Ricci, C. S.; Tufoni, M.; Bernardi, M. Clinical Indications for the Albumin Use: Still a Controversial Issue. Eur. J. Intern. Med. 2013, 24(8), 721–728. DOI: 10.1016/j.ejim.2013.05.015.
  • Rabin, J.; Meyenburg, T.; Lowery, A. V.; Rouse, M.; Gammie, J. S.; Herr, D. Restricted Albumin Utilization Is Safe and Cost Effective in a Cardiac Surgery Intensive Care Unit. Ann. Thorac. Surg. 2016. DOI: 10.1016/j.athoracsur.2016.10.018.
  • Kragh-Hansen, U. (2016) Human Serum Albumin: A Multifunctional Protein. In: Otagiri M., Chuang V. (eds) Albumin in Medicine. Singapore: Springer.
  • Nakae, H.; Tomida, K.; Kikuya, Y.; Okuyama, M.; Igarashi, T. Comparison of Quality of Human Serum Albumin Preparations in Two Pharmaceutical Products. Acute Med. Surg. 2017, 4(3), 251–254. DOI: 10.1002/ams2.259.
  • Karimi, M.; Bahrami, S.; Ravari, S. B.; Zangabad, P. S.; Mirshekari, H.; Bozorgomid, M.; Shahreza, S.; Sori, M.; Hamblin, M. R. Albumin Nanostructures as Advanced Drug Delivery Systems. Expert Opin. Drug Deliv. 2016, 13(11), 1609–1623. DOI: 10.1080/17425247.2016.1193149.
  • Amini-Geram, P.; Goshadrou, F.; Ebrahim-Habibi, A.; Yaghmaei, P.; Hesami-Tackallou, S., Human Serum Albumin Structure in Presence of Different Concentrations of Cortisol and Glucose: An in Vitro Modeling under Normal and Hyperglycemic Conditions. Iran Red. Crescent Med. J. 2017, 19, 3. DOI: 10.5812/ircmj.40306.
  • Sleep, D.;. Albumin and Its Application in Drug Delivery. Expert Opin. Drug Deliv. 2015, 12(5), 793–812. DOI: 10.1517/17425247.2015.993313.
  • Arasteh, A.; Farahi, S.; Habibi-Rezaei, M.; Moosavi-Movahedi, A. A. Glycated Albumin: An Overview of the in Vitro Models of an in Vivo Potential Disease Marker. J. Diabetes Metab. Disord. 2014, 13(1), 49. DOI: 10.1186/2251-6581-13-49.
  • Denizli, A.;. Plasma Fractionation: Conventional and Chromatographic Methods for Albumin Purification. Hacettepe J. Biol. Chem. 2011, 39(4), 315–341.
  • Raoufinia, R.; Mota, A.; Nozari, S.; Aghebati Maleki, L.; Balkani, S.; Abdolalizadeh, J. A Methodological Approach for Purification and Characterization of Human Serum Albumin. J. Immunoassay Immunochem. 2016, 37(6), 623–635. DOI: 10.1080/15321819.2016.1184163.
  • Mostafaie, A.; Abdolalizadeh, J.; Nomanpour, B.; Karimi, R.; Bahrami, Y. Immunogens of Brucella Abortus S19 Identified by Two-Dimensional Gel Electrophoresis and Immunoblotting. IJMS 2015, 30(1), 10–15.
  • Tanaka, K.; Shigueoka, E. M.; Sawatani, E.; Dias, G. A.; Arashiro, F.; Campos, T. C.; Nakao, H. C. Purification of Human Albumin by the Combination of the Method of Cohn with Liquid Chromatography. Braz. J. Med. Biol. Res. 1998, 31(11), 1383–1388. DOI: 10.1590/s0100-879x1998001100003.
  • Ding, Z.; Cao, X., Affinity Precipitation of Human Serum Albumin Using a Thermo-Response Polymer with an L-Thyroxin Ligand. BMC Biotechnol. 2013, 13, 109. DOI: 10.1186/1472-6750-13-109.
  • Grellet, S.; Martins, E. A.; Maimoni Goncalves, V.; Yague Lopes, A. P.; Raw, I.; Cabrera-Crespo, J. An Associated Process for the Purification of Immuno Globulin G, Catalase, Superoxide Dismutase and Albumin from Haemolysed Human Placenta Blood. Biotechnol. Appl. Biochem. 2001, 34(Pt 3), 135–142. DOI: 10.1042/ba20010023.
  • Odunuga, O. O.; Shazhko, A. Ammonium Sulfate Precipitation Combined with Liquid Chromatography Is Sufficient for Purification of Bovine Serum Albumin that Is Suitable for Most Routine Laboratory Applications. Biochem. Compounds 2013, 1(1), 3. DOI: 10.7243/2052-9341-1-3.
  • Vasileva, R.; Jakab, M.; Hasko, F., Application of Ion-Exchange Chromatography for the Production of Human Albumin. J. Chromatogr. A 1981, 216, 279–284. DOI: 10.1016/S0021-9673(00)82356-0.
  • Frerick, C.; Kreis, P.; Górak, A.; Tappe, A.; Melzner, D. Simulation of a Human Serum Albumin Downstream Process Incorporating Ion-Exchange Membrane Adsorbers. Chem. Eng. Process 2008, 47(7), 1128–1138. DOI: 10.1016/j.cep.2007.07.013.
  • Imamoglu, S.;, Simulated Moving Bed Chromatography (SMB) for Application in Bioseparation. Adv. Biochem. Eng. Biotechnol. 2002, 76, 211–231. DOI: 10.1007/3-540-45345-8_6.
  • Wang, C.; Bai, S.; Tao, S. P.; Sun, Y., Evaluation of Steric Exclusion Chromatography on Cryogel Column for the Separation of Serum Proteins. J. Chromatogr. A 2014, 1333, 54–59. DOI: 10.1016/j.chroma.2014.01.059.
  • Lihme, A.; Hansen, M. B.; Andersen, I. V.; Burnouf, T. A Novel Core Fractionation Process of Human Plasma by Expanded Bed Adsorption Chromatography. Anal. Biochem. 2010, 399(1), 102–109. DOI: 10.1016/j.ab.2009.12.002.
  • Balkani, S.; Shamekhi, S.; Raoufinia, R.; Parvan, R.; Abdolalizadeh, J. Purification and Characterization of Bovine Serum Albumin Using Chromatographic Method. Adv. Pharm. Bull. 2016, 6(4), 651–654. DOI: 10.15171/apb.2016.080.
  • Odabaşı, M.;. Magnetic Dye-Affinity Beads for Human Serum Albumin Purification. Prep. Biochem. Biotechnol. 2011, 41(3), 287–304. DOI: 10.1080/10826068.2010.540606.
  • Denizli, A.; Piskin, E. Dye-Ligand Affinity Systems. J. Biochem. Biophys. Methods 2001, 49(1–3), 391–416. DOI: 10.1016/S0165-022X(01)00209-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.